美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMGC Holdings

4.52

-0.0800-1.74%

盤後：4.580.0600+1.33%19:54 EDT

成交量：1.14萬

成交額：5.27萬

市值：365.93萬

市盈率：0.00

高：4.74

開：4.73

低：4.40

收：4.60

52周最高：2,671.20

52周最低：4.40

股本：80.96萬

流通股本：76.42萬

量比：0.48

換手率：1.49%

股息：- -

股息率：- -

每股收益(TTM):-1,801.7300

每股收益(LYR):-3,806.9050

淨資產收益率：-105.22%

總資產收益率：-32.97%

市淨率：0.22

市盈率(LYR):0.00

資料載入中...

總覽公司新聞公告

PMGC Holdings股價上漲，因其子公司擴大了針對人工智能發現的肥胖症和心臟病藥物項目的權益

Northstrive Biosciences修訂協議：獲心代謝領域獨家許可優先購買權

Northstrive Biosciences攜手Yuva Biosciences拓展AI驅動藥物發現項目，四款AI發現新化合物邁向候選藥提名，劍指心臟病與肥胖症治療領域

Northstrive Biosciences 擴展項目預計歷時6個月，最終將確定先導化合物提名

PMGC Holdings終止先前宣佈的收購意向書，經盡職調查後重申審慎併購策略並擴大航空航天與國防制造投資組合

PMGC Holdings與Orbit2orbit簽署條款清單：Northstrive Biosciences將啓動太空飛行研究，評估EL-22與EL-32對抗微重力肌肉流失的潛力

Northstrive Biosciences宣佈提交兩項美國專利申請針對長期太空飛行中微重力引發的肌肉流失問題

PMGC Holdings [納斯達克：Elab] 披露2026年第二季度財報並提交10-Q文件；總資產達3660萬美元，較2025年末激增184%，按年飆升290%，季度營收按月近乎翻倍

PMGC Holdings 宣佈戰略投資精密航空航天防務集團，並通過 a&B Aerospace 簽署長期航空航天製造協議

PMGC控股公司旗下阿蘇薩與聖安娜兩處生產基地將劃歸A&B宇航公司運營

Northstrive Biosciences提交兩項美國新專利申請，瞄準GLP-1及下一代肥胖治療市場的肌肉保護領域

Northstrive Defense Tech簽署具有約束力協議，獲得用於國防、航空航天及海事應用的多領域無人機載荷專利技術獨家授權

PMGC控股簽署無約束力意向書擬收購美國航空航天國防及半導體領域精密機械製造公司多數股權

Elevai Labs Q1營收大幅下滑，淨虧損擴大

环球市场播报

納斯達克上市公司PMGC Holdings發布2026年第一季度財報並提交10-Q表格；總資產突破2600萬美元，較2025年底激增102%，按年飆升193%

諾思創生物科學提交新美國專利申請涵蓋EL-22製劑及給藥方案用於治療GLP-1相關肌肉萎縮、少肌症、肌肉廢用性萎縮及特定神經系統疾病

Svm Machining與Turbo-Jet Products簽署長期協議，供應航空航天與國防關鍵部件

PMGC Holdings簽署4000萬美元股權融資協議宣佈加速航空航天與國防制造領域併購戰略

Northstrive Biosciences宣佈EL-32工作細胞庫運抵美國並啓動與Modulant Biosciences合作的雙重肌生長抑制素資產生產工藝優化，旨在結合GLP-1療法實現肌肉保護

PMGC Holdings旗下Northstrive保留EL-32人權授權 Modulant獲獨家動物健康許可

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ELAB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":4.52,"timestamp":1789156800000,"preClose":4.6,"halted":0,"volume":11402,"hourTrading":{"tag":"盘后","latestPrice":4.58,"preClose":4.52,"latestTime":"19:54 EDT","volume":684,"amount":3158.7878,"timestamp":1789170872166,"change":0.06,"changeRate":0.013274,"amplitude":0.028761},"delay":0,"changeRate":-0.017391304347826105,"floatShares":764190,"shares":809580,"eps":-1801.73,"marketStatus":"休市中","change":-0.08,"latestTime":"09-11 16:00:00 EDT","open":4.73,"high":4.7394,"low":4.4006,"amount":52663.808443999995,"amplitude":0.073652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1801.73,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":4.6,"preHourTrading":{"tag":"盘前","latestPrice":4.75,"preClose":4.6,"latestTime":"07:54 EDT","volume":309,"amount":1421.5499577,"timestamp":1789127697096,"change":0.15,"changeRate":0.032609,"amplitude":0.032609},"postHourTrading":{"tag":"盘后","latestPrice":4.58,"preClose":4.52,"latestTime":"19:54 EDT","volume":684,"amount":3158.7878,"timestamp":1789170872166,"change":0.06,"changeRate":0.013274,"amplitude":0.028761},"volumeRatio":0.47555889282060254},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":764190,"roa":"-32.97%","roe":"-105.22%","lyrEps":-3806.90497,"volumeRatio":0.47555889282060254,"shares":809580,"dividePrice":0,"high":4.7394,"amplitude":0.073652,"preClose":4.6,"low":4.4006,"week52Low":4.4006,"pbRate":"0.22","psRate":"1.42","week52High":2671.2,"institutionHeld":0,"latestPrice":4.52,"eps":-1801.73,"divideRate":0,"volume":11402,"delay":0,"ttmEps":-1801.73,"open":4.73,"prevYearClose":355.2,"prevWeekClose":5.21,"prevMonthClose":5.19,"prevQuarterClose":12.1,"fiveDayClose":5.23,"twentyDayClose":8.966,"sixtyDayClose":14.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-21","symbol":"ELAB","defaultRemindTime":1787319000000,"type":"split","dateTimestamp":1787284800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2026-08-14","symbol":"ELAB","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"","actualEps":-0.61},{"date":"2026-05-15","symbol":"ELAB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778832000000,"name":null,"time":"盤前","dateTimestamp":1778817600000,"actualEps":null},{"date":"2026-03-30","symbol":"ELAB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774857600000,"name":null,"time":"盤前","dateTimestamp":1774843200000,"actualEps":null},{"market":"US","date":"2026-03-10","symbol":"ELAB","defaultRemindTime":1773149400000,"type":"split","dateTimestamp":1773115200000,"forFactor":6,"toFactor":1,"ratio":6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2026-09-11","current":-0.002509,"percent":0.917647,"low":-19.933298,"twenty":-2.407092,"median":-0.687293,"eighty":-0.400839,"high":-0.098848,"avg":-1.568157,"sd":2.480958,"marketCap":3724063},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-28","current":-0.778466,"twenty":-3.336318,"median":-1.604046,"eighty":-0.955191,"marketCap":4257365},{"date":"2025-04-04","current":-0.500407,"twenty":-3.333578,"median":-1.540289,"eighty":-0.934537,"marketCap":3125408},{"date":"2025-04-11","current":-0.363417,"twenty":-3.331022,"median":-1.490993,"eighty":-0.836712,"marketCap":2269810},{"date":"2025-04-17","current":-0.292093,"twenty":-3.323718,"median":-1.4582,"eighty":-0.778466,"marketCap":1824333},{"date":"2025-04-25","current":-0.251335,"twenty":-3.263918,"median":-1.443055,"eighty":-0.679871,"marketCap":1569775},{"date":"2025-05-02","current":-0.270582,"twenty":-3.218269,"median":-1.417569,"eighty":-0.675289,"marketCap":1689983},{"date":"2025-05-09","current":-0.266053,"twenty":-3.204574,"median":-1.39741,"eighty":-0.646723,"marketCap":1661699},{"date":"2025-05-16","current":-0.262826,"twenty":-3.194988,"median":-1.384287,"eighty":-0.595535,"marketCap":1697054},{"date":"2025-05-23","current":-0.3205,"twenty":-3.194531,"median":-1.364277,"eighty":-0.557113,"marketCap":2069451},{"date":"2025-05-30","current":-0.451578,"twenty":-3.184305,"median":-1.354754,"eighty":-0.542732,"marketCap":2915816},{"date":"2025-06-06","current":-0.457969,"twenty":-3.174445,"median":-1.33918,"eighty":-0.520246,"marketCap":2957077},{"date":"2025-06-13","current":-0.462229,"twenty":-3.158012,"median":-1.322196,"eighty":-0.515702,"marketCap":2984585},{"date":"2025-06-20","current":-0.447318,"twenty":-3.151895,"median":-1.320411,"eighty":-0.500505,"marketCap":2888308},{"date":"2025-06-27","current":-0.462229,"twenty":-3.149977,"median":-1.313781,"eighty":-0.487953,"marketCap":2984585},{"date":"2025-07-03","current":-0.477139,"twenty":-3.149795,"median":-1.303555,"eighty":-0.473305,"marketCap":3080862},{"date":"2025-07-11","current":-0.48353,"twenty":-3.149247,"median":-1.292317,"eighty":-0.477139,"marketCap":3122123},{"date":"2025-07-18","current":-0.48779,"twenty":-3.145321,"median":-1.284002,"eighty":-0.477139,"marketCap":3149631},{"date":"2025-07-25","current":-0.49205,"twenty":-3.13537,"median":-1.275385,"eighty":-0.477991,"marketCap":3177139},{"date":"2025-08-01","current":-0.445188,"twenty":-3.121036,"median":-1.227076,"eighty":-0.474583,"marketCap":2874554},{"date":"2025-08-08","current":-0.401521,"twenty":-3.076573,"median":-1.214986,"eighty":-0.469471,"marketCap":2592600},{"date":"2025-08-15","current":-0.49292,"twenty":-3.005452,"median":-1.208035,"eighty":-0.467341,"marketCap":2763708},{"date":"2025-08-22","current":-0.500521,"twenty":-2.954964,"median":-1.18556,"eighty":-0.469471,"marketCap":2806323},{"date":"2025-08-29","current":-0.495224,"twenty":-2.921549,"median":-1.178457,"eighty":-0.470749,"marketCap":2776626},{"date":"2025-09-05","current":-0.329897,"twenty":-2.921549,"median":-1.174323,"eighty":-0.466061,"marketCap":1849668},{"date":"2025-09-12","current":-0.361676,"twenty":-2.921549,"median":-1.157467,"eighty":-0.462229,"marketCap":2027848},{"date":"2025-09-19","current":-0.461553,"twenty":-2.908834,"median":-1.129373,"eighty":-0.459878,"marketCap":2587839},{"date":"2025-09-26","current":-0.607461,"twenty":-2.85443,"median":-1.100858,"eighty":-0.45834,"marketCap":3405918},{"date":"2025-10-03","current":-0.656976,"twenty":-2.836945,"median":-1.075718,"eighty":-0.459878,"marketCap":3683538},{"date":"2025-10-10","current":-0.736683,"twenty":-2.82357,"median":-1.05413,"eighty":-0.46039,"marketCap":4130438},{"date":"2025-10-17","current":-0.939573,"twenty":-2.810275,"median":-1.051814,"eighty":-0.461688,"marketCap":5268001},{"date":"2025-10-24","current":-0.810904,"twenty":-2.759352,"median":-1.034145,"eighty":-0.462229,"marketCap":4546579},{"date":"2025-10-31","current":-0.800286,"twenty":-2.756693,"median":-1.007232,"eighty":-0.462229,"marketCap":4487049},{"date":"2025-11-07","current":-0.719328,"twenty":-2.748877,"median":-0.99388,"eighty":-0.462392,"marketCap":4033135},{"date":"2025-11-14","current":-0.731273,"twenty":-2.734696,"median":-0.983285,"eighty":-0.463309,"marketCap":4100106},{"date":"2025-11-21","current":-0.52978,"twenty":-2.711732,"median":-0.978673,"eighty":-0.464678,"marketCap":3549457},{"date":"2025-11-28","current":-0.589755,"twenty":-2.697229,"median":-0.972047,"eighty":-0.465954,"marketCap":3951282},{"date":"2025-12-05","current":-0.553104,"twenty":-2.663795,"median":-0.970216,"eighty":-0.466489,"marketCap":3705722},{"date":"2025-12-12","current":-0.456477,"twenty":-2.663183,"median":-0.965515,"eighty":-0.466489,"marketCap":3058337},{"date":"2025-12-19","current":-0.242122,"twenty":-2.655536,"median":-0.96081,"eighty":-0.462229,"marketCap":1622183},{"date":"2025-12-26","current":-0.177704,"twenty":-2.632488,"median":-0.955191,"eighty":-0.461262,"marketCap":1190593},{"date":"2026-01-02","current":-0.164376,"twenty":-2.622825,"median":-0.955191,"eighty":-0.457372,"marketCap":1101299},{"date":"2026-01-09","current":-0.154658,"twenty":-2.620016,"median":-0.948505,"eighty":-0.454987,"marketCap":1036187},{"date":"2026-01-16","current":-0.103013,"twenty":-2.619153,"median":-0.932716,"eighty":-0.451373,"marketCap":690171},{"date":"2026-01-23","current":-0.642466,"twenty":-2.615446,"median":-0.915859,"eighty":-0.451578,"marketCap":4304435},{"date":"2026-01-30","current":-0.589369,"twenty":-2.605938,"median":-0.857118,"eighty":-0.451636,"marketCap":3948697},{"date":"2026-02-06","current":-0.28318,"twenty":-2.598448,"median":-0.825353,"eighty":-0.45127,"marketCap":1897272},{"date":"2026-02-13","current":-0.247783,"twenty":-2.592001,"median":-0.81256,"eighty":-0.445188,"marketCap":1660113},{"date":"2026-02-20","current":-0.703104,"twenty":-2.58341,"median":-0.806258,"eighty":-0.445188,"marketCap":4710707},{"date":"2026-02-27","current":-0.610973,"twenty":-2.582485,"median":-0.794977,"eighty":-0.445586,"marketCap":4093442},{"date":"2026-03-06","current":-0.342097,"twenty":-2.577205,"median":-0.78801,"eighty":-0.445586,"marketCap":2292003},{"date":"2026-03-13","current":-0.355593,"twenty":-2.566434,"median":-0.778466,"eighty":-0.440568,"marketCap":2382428},{"date":"2026-03-20","current":-0.306295,"twenty":-2.548508,"median":-0.76506,"eighty":-0.437027,"marketCap":2052137},{"date":"2026-03-27","current":-0.151127,"twenty":-2.546818,"median":-0.759629,"eighty":-0.431287,"marketCap":1012532},{"date":"2026-04-02","current":-0.978399,"twenty":-2.542123,"median":-0.751181,"eighty":-0.429017,"marketCap":7580454},{"date":"2026-04-10","current":-1.314876,"twenty":-2.536364,"median":-0.763457,"eighty":-0.430278,"marketCap":10187415},{"date":"2026-04-17","current":-0.95241,"twenty":-2.532982,"median":-0.77507,"eighty":-0.431287,"marketCap":7379097},{"date":"2026-04-24","current":-0.834527,"twenty":-2.532982,"median":-0.784801,"eighty":-0.431287,"marketCap":6465759},{"date":"2026-05-01","current":-1.413088,"twenty":-2.507089,"median":-0.786351,"eighty":-0.43398,"marketCap":10948345},{"date":"2026-05-08","current":-1.240761,"twenty":-2.495456,"median":-0.794314,"eighty":-0.434538,"marketCap":9613181},{"date":"2026-05-15","current":-1.208099,"twenty":-2.495456,"median":-0.801613,"eighty":-0.436584,"marketCap":9360127},{"date":"2026-05-22","current":-0.679111,"twenty":-2.495456,"median":-0.797632,"eighty":-0.438798,"marketCap":7542626},{"date":"2026-05-29","current":-0.785478,"twenty":-2.480446,"median":-0.791659,"eighty":-0.438798,"marketCap":8724001},{"date":"2026-06-05","current":-0.691384,"twenty":-2.476393,"median":-0.785478,"eighty":-0.438798,"marketCap":7678939},{"date":"2026-06-12","current":-0.638201,"twenty":-2.461602,"median":-0.776768,"eighty":-0.440053,"marketCap":7088251},{"date":"2026-06-18","current":-0.585017,"twenty":-2.456804,"median":-0.76739,"eighty":-0.44097,"marketCap":6497563},{"date":"2026-06-26","current":-0.47456,"twenty":-2.447787,"median":-0.762462,"eighty":-0.442384,"marketCap":5270751},{"date":"2026-07-02","current":-0.523652,"twenty":-2.441181,"median":-0.751181,"eighty":-0.44391,"marketCap":5816001},{"date":"2026-07-10","current":-0.433649,"twenty":-2.437065,"median":-0.73858,"eighty":-0.442046,"marketCap":4816376},{"date":"2026-07-17","current":-0.445922,"twenty":-2.427224,"median":-0.731273,"eighty":-0.442322,"marketCap":4952688},{"date":"2026-07-24","current":-0.388198,"twenty":-2.417717,"median":-0.724112,"eighty":-0.438798,"marketCap":4311565},{"date":"2026-07-31","current":-0.388361,"twenty":-2.417232,"median":-0.720821,"eighty":-0.43774,"marketCap":4313382},{"date":"2026-08-07","current":-0.39098,"twenty":-2.416511,"median":-0.71593,"eighty":-0.433715,"marketCap":4342462},{"date":"2026-08-14","current":-0.366802,"twenty":-2.413146,"median":-0.709793,"eighty":-0.43048,"marketCap":4073927},{"date":"2026-08-21","current":-0.205529,"twenty":-2.410856,"median":-0.703402,"eighty":-0.426313,"marketCap":2771687},{"date":"2026-08-28","current":-0.34999,"twenty":-2.409301,"median":-0.700941,"eighty":-0.414208,"marketCap":4719845},{"date":"2026-09-04","current":-0.313971,"twenty":-2.408074,"median":-0.691384,"eighty":-0.406404,"marketCap":4234098},{"date":"2026-09-11","current":-0.27615,"twenty":-2.407092,"median":-0.687293,"eighty":-0.400839,"marketCap":3724063}],"updateTime":1789318800527},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664856450","title":"PMGC Holdings股價上漲，因其子公司擴大了針對人工智能發現的肥胖症和心臟病藥物項目的權益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856450","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856450?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 20:03","pubTimestamp":1788264238,"startTime":"0","endTime":"0","summary":"BUZZ-PMGC Holdings股价上涨，因其子公司扩大了针对人工智能发现的肥胖症和心脏病药物项目的权益9月1日-** 多元化控股公司 PMGC HoldingsELAB.O的股价在盘前交易中上涨 5.8%，至 5.49 美元** 该公司表示，旗下子公司NorthStrive Biosciences已修订与Yuva Biosciences达成的协议，以推进四个由人工智能发现、针对肥胖症和心脏病","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119097901","title":"Northstrive Biosciences修訂協議：獲心代謝領域獨家許可優先購買權","url":"https://stock-news.laohu8.com/highlight/detail?id=1119097901","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119097901?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:48","pubTimestamp":1788263302,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences近日宣布，其对相关协议进行了修订。此次修订赋予公司在心代谢领域获得独家许可的优先购买权（Right of First Refusal）。这一权利意味着，在特定条件下，公司拥有优先洽谈并获取该领域独家许可的机会。此举可能为公司在该赛道的战略布局增添重要筹码，亦反映出其深耕心代谢领域的意图与决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126537446","title":"Northstrive Biosciences攜手Yuva Biosciences拓展AI驅動藥物發現項目，四款AI發現新化合物邁向候選藥提名，劍指心臟病與肥胖症治療領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1126537446","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126537446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:48","pubTimestamp":1788263296,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences正加速推进其人工智能驱动的药物发现计划，与Yuva Biosciences达成合作，进一步深化双方在创新疗法研发上的协同布局。此举有望为心脏病及肥胖症等重大代谢与心血管疾病带来更具潜力的治疗选择。据悉，该进展标志着Northstrive在AI赋能制药赛道上的又一重要里程碑，也折射出跨学科合作在新药研发中的日益凸显的核心价值。随着项目不断深入，业界正密切关注这些AI衍生分子能否顺利通过临床前验证，进而引领下一代精准医疗方案的变革。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164353142","title":"Northstrive Biosciences 擴展項目預計歷時6個月，最終將確定先導化合物提名","url":"https://stock-news.laohu8.com/highlight/detail?id=1164353142","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164353142?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:46","pubTimestamp":1788263170,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences宣布，其扩展项目预计将持续六个月，并最终达到先导化合物提名阶段。这一进程被视作公司研发管线推进的关键节点，标志着从早期探索向候选药物筛选迈出实质性步伐。据悉，该项目的时间框架设定明确，旨在高效整合资源，加速创新疗法的孵化。随着项目的深入，业界将密切关注其阶段性成果及对后续临床开发的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121606266","title":"PMGC Holdings終止先前宣佈的收購意向書，經盡職調查後重申審慎併購策略並擴大航空航天與國防制造投資組合","url":"https://stock-news.laohu8.com/highlight/detail?id=1121606266","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121606266?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 20:17","pubTimestamp":1787746676,"startTime":"0","endTime":"0","summary":"在完成全面尽职调查审查之后，PMGC Holdings正式宣布终止此前公布的收购意向书。该公司同时重申其秉持审慎态度的并购战略，并进一步拓展在航空航天及国防制造领域的投资版图。这一决定标志着PMGC Holdings在交易评估过程中采取了严谨而理性的立场。经过深入细致的考察，公司选择放弃该潜在收购项目，转而将资源聚焦于更具战略价值的领域。PMGC Holdings强调，其并购策略始终以纪律性和价值创造为核心导向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143253696","title":"PMGC Holdings與Orbit2orbit簽署條款清單：Northstrive Biosciences將啓動太空飛行研究，評估EL-22與EL-32對抗微重力肌肉流失的潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1143253696","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143253696?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:31","pubTimestamp":1787657486,"startTime":"0","endTime":"0","summary":"PMGC Holdings宣布，其旗下Northstrive Biosciences已与Orbit2orbit达成一份条款清单协议，计划开展一项太空飞行研究，专门评估该公司在肌生成抑制蛋白与激活素A领域的在研资产——EL-22及EL-32——对微重力所诱发肌肉流失的干预效果。这一合作标志着Northstrive Biosciences在空间医学探索中迈出关键一步。PMGC Holdings方面表示，此次合作充分体现了公司在拓展生物医药应用边界上的决心——从地球延伸至轨道，从常规临床走向极端环境验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103508117","title":"Northstrive Biosciences宣佈提交兩項美國專利申請 針對長期太空飛行中微重力引發的肌肉流失問題","url":"https://stock-news.laohu8.com/highlight/detail?id=1103508117","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103508117?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:31","pubTimestamp":1787319076,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences今日宣布，已正式提交两项美国专利申请，旨在应对长期太空飞行过程中由微重力环境所诱导的肌肉流失难题。这一举措标志着该公司在太空医疗健康领域迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116872376","title":"PMGC Holdings [納斯達克：Elab] 披露2026年第二季度財報並提交10-Q文件；總資產達3660萬美元，較2025年末激增184%，按年飆升290%，季度營收按月近乎翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1116872376","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116872376?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:34","pubTimestamp":1786714481,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc.（纳斯达克股票代码：Elab）今日正式发布了2026年第二季度的财务业绩，并同步向监管机构提交了10-Q表格。公司业绩表现颇为亮眼，多项核心指标录得强劲增长。截至报告期末，公司总资产规模已攀升至3660万美元。这一数字相较于2025年年底的数据，实现了高达184%的惊人增幅；若与去年同期相比，增长幅度更是达到了290%。与此同时，季度营收也呈现出显著的增长势头，较上一季度几乎实现翻番，展现出强劲的业务扩张能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109673512","title":"PMGC Holdings 宣佈戰略投資精密航空航天防務集團，並通過 a&B Aerospace 簽署長期航空航天製造協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1109673512","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109673512?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:31","pubTimestamp":1785238270,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc.（股票代码：ELAB）近日发布重大公告。该公司将战略投资于 Precision Aerospace & Defense Group，并与之达成一项长期合作。不仅如此，PMGC Holdings 还通过其关联方 a&B Aerospace Inc.，正式签署了一份航空航天与防务领域的制造协议。这一举措标志着公司在高端制造领域迈出了关键一步。此次战略布局，不仅旨在强化其产业纵深，更着眼于未来航空市场的长期增长潜力。通过整合资源与深化合作，PMGC Holdings 正加速其在精密制造赛道上的战略卡位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130804390","title":"PMGC控股公司旗下阿蘇薩與聖安娜兩處生產基地將劃歸A&B宇航公司運營","url":"https://stock-news.laohu8.com/highlight/detail?id=1130804390","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130804390?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 19:34","pubTimestamp":1783337655,"startTime":"0","endTime":"0","summary":"PMGC控股公司宣布，其位于阿苏萨和圣安娜的两处制造工厂将继续运营，但将划归A&B宇航公司旗下管理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175176663","title":"Northstrive Biosciences提交兩項美國新專利申請，瞄準GLP-1及下一代肥胖治療市場的肌肉保護領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1175176663","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175176663?lang=zh_tw&edition=fundamental","pubTime":"2026-06-18 19:34","pubTimestamp":1781782496,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences已正式提交两项美国专利申请，其核心目标直指在GLP-1药物及下一代肥胖治疗市场中至关重要的肌肉保护问题。此举旨在巩固公司在相关前沿治疗领域的知识产权布局，应对伴随减重疗法可能出现的肌肉流失挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162237534","title":"Northstrive Defense Tech簽署具有約束力協議，獲得用於國防、航空航天及海事應用的多領域無人機載荷專利技術獨家授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1162237534","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162237534?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 19:33","pubTimestamp":1780918421,"startTime":"0","endTime":"0","summary":"Northstrive Defense Tech已执行一项具有约束力的协议，以获取一项专利多领域无人机载荷技术的独家授权。该技术专为国防、航空航天及海事领域的应用而设计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187952512","title":"PMGC控股簽署無約束力意向書 擬收購美國航空航天國防及半導體領域精密機械製造公司多數股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1187952512","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187952512?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 19:33","pubTimestamp":1780313582,"startTime":"0","endTime":"0","summary":"PMGC控股公司已签署一份无约束力意向书，计划收购一家美国精密机械制造公司的多数股权。该公司业务范围广泛，深度服务于航空航天、太空探索、国防以及半导体等高精尖行业市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035716","title":"Elevai Labs Q1營收大幅下滑，淨虧損擴大","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035716","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035716?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 23:43","pubTimestamp":1778859780,"startTime":"0","endTime":"0","summary":"　　Elevai Labs公布2026年第一季度财报。公司报告期内营收为30.5万美元，相比去年同期的86.8万美元大幅下降65%。净亏损为222.9万美元，较去年同期的净亏损142.5万美元进一步扩大，合每股亏损0.13美元。　　Elevai Labs是一家专注于医学美容领域的生物技术公司，主要开发基于外泌体的创新护肤产品。公司同时强调了其在高端医美市场的产品布局，预计未来将通过扩大营销投入来提升品牌知名度和市场份额。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-15/doc-inhxyyii5160377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102597324","title":"納斯達克上市公司PMGC Holdings發布2026年第一季度財報並提交10-Q表格；總資產突破2600萬美元，較2025年底激增102%，按年飆升193%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102597324","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102597324?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:12","pubTimestamp":1778843558,"startTime":"0","endTime":"0","summary":"PMGC Holdings（纳斯达克股票代码：ELAB）公布了其2026年第一季度的财务业绩，并已向美国证券交易委员会提交了相应的10-Q表格。报告显示，公司总资产规模已超过2600万美元，这一数字与2025年年底相比实现了102%的惊人增长，与去年同期相比更是大幅跃升了193%。\n这份亮眼的资产增长数据，凸显了公司在过去一段时间内的快速扩张态势。提交10-Q表格是上市公司按季度向监管机构披露未经审计财务报表的法定义务，此举标志着公司已按时完成了本季度的财务信息披露工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162597728","title":"諾思創生物科學提交新美國專利申請 涵蓋EL-22製劑及給藥方案 用於治療GLP-1相關肌肉萎縮、少肌症、肌肉廢用性萎縮及特定神經系統疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1162597728","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162597728?lang=zh_tw&edition=fundamental","pubTime":"2026-04-29 04:01","pubTimestamp":1777406480,"startTime":"0","endTime":"0","summary":"诺思创生物科学公司近日向美国专利商标局提交了一项新的专利申请，该申请全面覆盖其创新药物EL-22的制剂配方与给药方案。这项专利技术的治疗范围颇具前瞻性，主要针对四大疾病领域：GLP-1药物使用引发的肌肉萎缩并发症、老年性少肌症、肌肉废用性萎缩综合征，以及某些特定类型的神经系统疾病。在人口老龄化加剧的背景下，该专利涉及的少肌症治疗市场潜力巨大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119387402","title":"Svm Machining與Turbo-Jet Products簽署長期協議，供應航空航天與國防關鍵部件","url":"https://stock-news.laohu8.com/highlight/detail?id=1119387402","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119387402?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 19:31","pubTimestamp":1776771107,"startTime":"0","endTime":"0","summary":"Svm Machining公司已与Turbo-Jet Products公司正式达成一项长期供应协议，将为后者提供用于航空航天与国防领域的关键任务部件。此次合作标志着Svm Machining在高精度制造领域的专业能力获得重要认可，同时也为Turbo-Jet Products公司确保了关键零部件供应链的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188388695","title":"PMGC Holdings簽署4000萬美元股權融資協議 宣佈加速航空航天與國防制造領域併購戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1188388695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188388695?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 19:32","pubTimestamp":1776425574,"startTime":"0","endTime":"0","summary":"PMGC Holdings（纳斯达克代码：ELAB）已成功获得4000万美元股权融资额度协议，此举将显著增强公司推进并购战略的资金实力。该战略当前聚焦于收购航空航天及国防制造领域的企业。\n通过这项融资安排，公司获得了可灵活调动的资本支持，为加速实施既定的并购计划创造了有利条件。此次融资将主要用于瞄准航空航天与国防制造行业的优质标的，进一步扩大公司在高精尖制造领域的产业布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122587787","title":"Northstrive Biosciences宣佈EL-32工作細胞庫運抵美國並啓動與Modulant Biosciences合作的雙重肌生長抑制素資產生產工藝優化，旨在結合GLP-1療法實現肌肉保護","url":"https://stock-news.laohu8.com/highlight/detail?id=1122587787","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122587787?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:35","pubTimestamp":1776080107,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences已正式宣布，其EL-32工作细胞库成功运抵美国。与此同时，公司与Modulant Biosciences展开合作，正式启动了针对双重肌生长抑制素资产的生产工艺优化项目。该项目核心目标在于，通过优化制造流程，开发能够与GLP-1疗法协同作用、专注于肌肉保护的新型疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115118521","title":"PMGC Holdings旗下Northstrive保留EL-32人權授權 Modulant獲獨家動物健康許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1115118521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115118521?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:34","pubTimestamp":1776080046,"startTime":"0","endTime":"0","summary":"PMGC Holdings宣布，其子公司Northstrive将保留EL-32化合物在人类医疗领域的全球开发与商业化权利。与此同时，合作企业Modulant获得了该化合物在动物健康领域的独家授权许可。\n此次授权划分明确了双方在EL-32应用领域的商业边界。Northstrive将继续推进EL-32在人类疾病治疗方面的临床研究，而Modulant将专注于开发针对伴侣动物和畜牧动物的新型治疗方案。\n这一战略安排有助于双方集中资源深耕各自专业领域，为EL-32的商业化路径提供更明确的发展方向。化合物授权范围的细分也体现了精准医疗时代下知识产权管理的精细化趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}